Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) dropped 8.2% during mid-day trading on Monday . The stock traded as low as $1.79 and last traded at $1.7999. Approximately 291,299 shares traded hands during mid-day trading, an increase of 425% from the average daily volume of 55,481 shares. The stock had previously closed at $1.96.
Alpha Tau Medical Stock Performance
The company has a 50 day simple moving average of $1.74 and a 200 day simple moving average of $1.14.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
Featured Articles
- Five stocks we like better than Alpha Tau Medical
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
